BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21466723)

  • 21. The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still's disease.
    Nigrovic PA; de Benedetti F; Kimura Y; Lovell DJ; Vastert SJ
    Pediatr Rheumatol Online J; 2024 Jan; 21(Suppl 1):114. PubMed ID: 38183114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous Panniculitis-like T-cell Lymphoma Lacking Subcutaneous Tumor Mimicking Adult-onset Still's Disease.
    Tada M; Kachi S; Onozawa M; Fujieda Y; Yoshida S; Oki Y; Kamada K; Nagai J; Okada S; Kikuchi R; Hisada R; Hasegawa Y; Ohigashi H; Goto H; Hashimoto D; Nakazato S; Matsuno Y; Teshima T; Atsumi T
    Intern Med; 2023 Nov; 62(21):3231-3235. PubMed ID: 36927968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease.
    Yoshihara R; Tsuchiya H; Shoda H; Fujio K
    Scand J Rheumatol; 2024 Jul; 53(4):284-287. PubMed ID: 38314790
    [No Abstract]   [Full Text] [Related]  

  • 24. Routine biomarker profile for the prediction of clinical phenotypes of adult-onset Still's disease using unsupervised clustering algorithm.
    Gallardo-Pizarro A; Campos-Rodríguez V; Martín-Iglesias D; Ruiz-Irastorza G
    Int J Rheum Dis; 2024 Apr; 27(4):e15143. PubMed ID: 38576108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of emapalumab in macrophage activation syndrome.
    De Benedetti F; Grom AA; Brogan PA; Bracaglia C; Pardeo M; Marucci G; Eleftheriou D; Papadopoulou C; Schulert GS; Quartier P; Antón J; Laveille C; Frederiksen R; Asnaghi V; Ballabio M; Jacqmin P; de Min C
    Ann Rheum Dis; 2023 Jun; 82(6):857-865. PubMed ID: 37001971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Online survey of COVID-19 immunization and infection in patients with systemic juvenile idiopathic arthritis and adult-onset still's disease.".
    Marques MC; Paul S; Lake C; Bergeron LL; Sinha R; Peixoto L; Twilt M; Ombrello MJ
    Pediatr Rheumatol Online J; 2023 Nov; 21(1):139. PubMed ID: 37990257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of 5-aminolevulinic acid in adult-onset Still's disease: A preclinical study in mice and a pilot study in humans.
    Koga T; Sumiyoshi R; Tsuji Y; Kodama K; Endo Y; Furukawa K; Kawakami A
    Clin Immunol; 2023 Dec; 257():109846. PubMed ID: 38007033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metagenomic next-generation sequencing on bronchoalveolar lavage fluid to contribute to diagnosis of subclinical pulmonary tuberculosis with scarce sputum and negative smear in a patient mimicking adult- onset still's disease: A case report.
    Guan Y; Ma X; Sun X; Zhang H
    Diagn Microbiol Infect Dis; 2024 Mar; 108(3):116165. PubMed ID: 38176299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Biological Drugs in Still's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Kilic B; Ozturk A; Karup S; Hacioglu E; Ugurlu S
    Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38775654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Not All Fevers Equal Infection: A Challenging Case of Adult-Onset Still's Disease.
    Ukoha N; Olaosebikan K; Berchie P; Ansari FA; Nlandu Z
    Cureus; 2024 May; 16(5):e59968. PubMed ID: 38854353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiorgan Dysfunction in a Patient With Adult-Onset Still's Disease Flare: A Case Report.
    Arya P V A; Vangipuram DR; Rondla M; Unnikrishnan D
    Cureus; 2024 May; 16(5):e60400. PubMed ID: 38883113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review.
    Marazzi F; Masiello V; Franceschini G; Bosello S; Moschella F; Smaniotto D; Luzi S; Mulé A; Gambacorta MA; Gremese E; Masetti R; Valentini V
    Rep Pract Oncol Radiother; 2020; 25(4):527-532. PubMed ID: 32477018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
    Mavragani CP; Spyridakis EG; Koutsilieris M
    Int J Inflam; 2012; 2012():879020. PubMed ID: 22792508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal myocarditis in a child with systemic onset juvenile idiopathic arthritis during treatment with an interleukin 1 receptor antagonist.
    Zeft AS; Menon SC; Miller D
    Pediatr Rheumatol Online J; 2012 Apr; 10():8. PubMed ID: 22490470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erratum in: Budget Impact Analysis of anakinra in the treatment of patients with Still's Disease.
    Ravasio R; Giacomelli R; Bianchi S
    Glob Reg Health Technol Assess; 2020; 7():91. PubMed ID: 36643911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy.
    Giampietro C; Ridene M; Lequerre T; Costedoat Chalumeau N; Amoura Z; Sellam J; Sibilia J; Bourgeois P; Fautrel B;
    Arthritis Care Res (Hoboken); 2013 May; 65(5):822-6. PubMed ID: 23225779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based clinical practice guideline for adult Still's disease.
    Mimura T; Kondo Y; Ohta A; Iwamoto M; Ota A; Okamoto N; Kawaguchi Y; Kono H; Takasaki Y; Takei S; Nishimoto N; Fujimoto M; Asanuma YF; Mimori A; Okiyama N; Kaneko S; Takahashi H; Yokosawa M; Sumida T
    Mod Rheumatol; 2018 Sep; 28(5):736-757. PubMed ID: 29651907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anakinra in children and adults with Still's disease.
    Vastert SJ; Jamilloux Y; Quartier P; Ohlman S; Osterling Koskinen L; Kullenberg T; Franck-Larsson K; Fautrel B; de Benedetti F
    Rheumatology (Oxford); 2019 Nov; 58(Suppl 6):vi9-vi22. PubMed ID: 31769856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W; Starmans-Kool M; Peeters RM
    Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.